Drug for Duchenne Muscular Dystrophy Sails Through FDA Approval, Questioned by Shareholders
https://pixabay.com/en/pill-capsule-flying-many-horde-1884777/

Drug for Duchenne Muscular Dystrophy Sails Through FDA Approval, Questioned by Shareholders

Duchenne muscular dystrophy (DMD) is a particularly cruel genetic disease. It most commonly affects boys, who by the age of three, begin to experience muscle weakness in the legs, hips…

Continue Reading Drug for Duchenne Muscular Dystrophy Sails Through FDA Approval, Questioned by Shareholders
2017 Muscular Dystrophy Association Scientific Conference: A Beacon of Light!
mohamed_hassan / Pixabay

2017 Muscular Dystrophy Association Scientific Conference: A Beacon of Light!

2017 Muscular Dystrophy Association Scientific Conference was a beacon of light! Researchers from academic medical centers,  pharmaceutical companies, children’s’ medical centers, biotech, engineering,  and veterinary medicine came together to share…

Continue Reading 2017 Muscular Dystrophy Association Scientific Conference: A Beacon of Light!